Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: art slott who wrote (937)	3/25/1999 10:33:00 AM
From: Wayners	Read Replies (1) \| Respond to of 1837

When do the upgrades come out?

To: art slott who wrote (937)	3/25/1999 2:01:00 PM
From: johnlag	Read Replies (4) \| Respond to of 1837

Anyone understand this drug's market and competition? Please read this post. To: johnlag (24110 ) From: Instock Thursday, Mar 25 1999 1:55PM ET Reply # of 24123 < DRMD > If I understand the Press Release correctly, and some comments made by others.. " The FDA did not find Cenestin equivalent to Premarin and limited the approval to treating menopausal symptoms such as hot flashes. Unlike Premarin, Cenestin won't be approved for long- term use, including the treatment of osteoporosis, and pharmacists won't be able to replace Premarin with Cenestin. " From Yahoo Post: Seems to make since after re reading Press Release If this IS the case, then the stock is VERY Over Bought. Can someone concure with this? Instock